Brigit Biofarmaka Teknologi Tbk. vs Sat Nusapersada Tbk — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp254 (market cap 172.82B, 592.2K 24h volume), while Sat Nusapersada Tbk trades at Rp246 (market cap 1.33T, 217K 24h volume). The key difference: Sat Nusapersada Tbk is far larger — about 7.7× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (592.2K versus 217K). Which is the better fit depends on your goals.
| OBAT | PTSN | |
|---|---|---|
Market Cap | 172.82B | 1.33T |
Volume | 592.2K | 217K |
Lot | 5.92K | 2.17K |
Turnover | 147.05M | 53.62M |
Average Price | 248.31 | 247.12 |
Value | 147.05M | 53.62M |
Indicative Equilibrium Price | 254 | 246 |
Indicative Equilibrium Volume | 10 | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →Sat Nusapersada Tbk (the company) was established on Jun 1, 1990 based on Notaries Deed No. 5 and the deed of establishment was approved by the the Ministry of Justice dated Sept 18, 1991. The Company’s articles of association has been amended several times, most recently by notarial deed No. 14 of Fathiah Helmi, S.H., dated Aug 7, 2007, concerning public offering.
Read more on PTSN →